The Hong Kong Special Administrative Region Government plans to launch plans in the fourth quarter to fund the screening and treatment of chronic diseases.
According to the Hong Kong News Agency, Hong Kong is promoting grass -roots medical care, and the Hong Kong government intends to launch a pilot plan for chronic diseases in the fourth quarter to fund qualified persons to screen and diagnose chronic diseases in private medical institutions.Pay with the government.
Li Xiayin, deputy director of the Hong Kong Medical and Health Bureau, said on a radio program on Monday (July 17) that the government does not exempt relevant costs and hopes that citizens will become their "first health leaders".
She said that the above plan is tentatively scheduled for three years, and the official will conduct mid -term review to study whether the plan should be further expanded and reviewing the implementation model.
It is reported that the treatment stage under the planned plan is 150 yuan each time (Hong Kong dollars, the same below, about S $ 25).In order to encourage patients to reach a health indicator, if the participants are well controlled by the blood sugar levels, the next year will be exempted from the first year, and the first time can be exempted from up to 150 Hong Kong dollars, and the doctor can also receive about 15%of the reward.
There are opinions, whether the doctor will prescribe the old medicine for cost considerations.Li Xiayin responded that doctors should use the clinical guidelines for the project to prescribe suitable drugs for patients.She hopes that through the development of grass -roots medical care, the establishment of a community drug roster, with a central procurement method, and using a relatively cheap price to buy medicine from the drug supplier of the Hospital Management Bureau, it also plans to gradually broaden the list of drugs to cover patented drugs.
The former president of the Hong Kong Western Medicine Union and the family doctor Yang Chao Fa's attention to the cost of diagnosis is only enough to cover the cost of the basic drug of the prescription. Some of the newer drug costs per month may be as high as 500 yuan.He suggested that the official consideration is incorporated into more new medicines in the planned drug roster, otherwise the old medicine will not work, and the doctor may refer to the public hospital to follow up.
